scholarly journals Calcium Chloride and Calcium Gluconate in Neonatal Parenteral Nutrition Solutions without Cysteine: Compatibility Studies Using Laser Light Obscuration Methodology

Nutrients ◽  
2018 ◽  
Vol 10 (2) ◽  
pp. 208 ◽  
Author(s):  
Robert Huston ◽  
J. Christensen ◽  
Sultan Alshahrani ◽  
Sumeia Mohamed ◽  
Carl Heisel
2018 ◽  
Vol 43 (3) ◽  
pp. 426-433 ◽  
Author(s):  
Robert K. Huston ◽  
J. Mark Christensen ◽  
Sultan M. Alshahrani ◽  
Sumeia M. Mohamed ◽  
Carl F. Heisel ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0136894 ◽  
Author(s):  
Robert K. Huston ◽  
J. Mark Christensen ◽  
Sultan M. Alshahrani ◽  
Sumeia M. Mohamed ◽  
Sara M. Clark ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (9) ◽  
pp. e106825 ◽  
Author(s):  
Robert K. Huston ◽  
J. Mark Christensen ◽  
Chanida Karnpracha ◽  
Jill E. Rosa ◽  
Sara M. Clark ◽  
...  

Pharmaceutics ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 1092
Author(s):  
Szymon Tomczak ◽  
Maciej Stawny ◽  
Anna Jelińska

Parenteral nutrition (PN) admixtures are prone to interacting with drugs administered intravenously via a common catheter. This may cause a threat to a patient’s health and life. The literature that has been reported on the compatibility of loop diuretics with PN presents conflicting results. This work aimed to study the compatibility of furosemide and torsemide with PN used in clinical practice. Undiluted solutions of drugs were mixed with PN at various ratios determined by flow rates. In order to assess compatibility, visual control was followed by pH measurement, osmolality, mean emulsion droplet diameter (MDD), and zeta potential upon mixing and at 4 h of storage. No macroscopic changes that indicated lipid emulsion degradation were observed. After the addition of the drugs, the value of pH ranged from 6.37 ± 0.01 to 7.38 ± 0.01. The zeta potential was in reverse proportion to the drug concentration. The addition of the drugs did not affect the MDD. It may be suggested that the co-administration of furosemide or torsemide and PN caused no interaction. The absence of such signs of unwanted interactions allowed for the co-administration of the mentioned loop diuretics and PN at each of the studied ratios.


1980 ◽  
Vol 37 (5) ◽  
pp. 673-674 ◽  
Author(s):  
R. Scott Henry ◽  
Raymond W. Jurgens ◽  
Roy Sturgeon ◽  
Narayan Athanikar ◽  
Alan Welco ◽  
...  

2012 ◽  
Vol 36 (4) ◽  
pp. 470-475 ◽  
Author(s):  
Evelyn A. Migaki ◽  
Brian J. Melhart ◽  
Christina J. Dewar ◽  
Robert K. Huston

2013 ◽  
Vol 27 (5) ◽  
pp. 474-477 ◽  
Author(s):  
Kevin E. Anger ◽  
Caryn Belisle ◽  
Megan B. Colwell ◽  
Robert Dannemiller ◽  
Burhan Alawadhi ◽  
...  

Calcium gluconate is preferred over calcium chloride for intravenous (IV) repletion of calcium deficiencies in the inpatient setting. In the setting of a national shortage of IV calcium gluconate, our institution implemented a compounded calcium chloride admixture for IV administration. The objective of this analysis is to evaluate the peripheral infusion site safety of compounded IV calcium chloride admixtures in adult inpatients. A total of 222 patients, encompassing 224 inpatient admissions, from April to June 2011 were retrospectively reviewed. Sterile preparations of calcium chloride in 5% dextrose (600 mg/250 mL and 300 mg/100 mL) were used during the study time period. Adverse infusion site reactions were assessed using an institutional infiltration and phlebitis grading system. A total of 333 doses were administered peripherally. In all, 4 (1.8%) patients experienced a moderate to severe infusion site reaction, with 3 due to phlebitis and 1 due to infiltration. Naranjo Nomogram for Adverse Drug Reaction Assessment classified all 4 reactions to have a possible link to calcium chloride administration. Peripheral administration of compounded calcium chloride admixtures in 5% dextrose is associated with a low incidence of IV infusion site reactions and can be considered as an alternative in the event of a calcium gluconate shortage.


Sign in / Sign up

Export Citation Format

Share Document